Appearing as a significant breakthrough in the struggle against obesity, the drug is capturing considerable attention . This treatment combines properties of two known GLP-1 receptor agonists, semaglutide , and an unique glucose-dependent incretin component. Initial study results have demonstrated significant fat decrease in individuals with ex… Read More